Clinical Trial Update: Inhaled Corticosteroid Use to Prevent Acute Chest Syndrome Recurrence in Children Between 1 and 4 With Sickle Cell Disease: a Feasibility Trial [Phase 1]

View source ↗

Summary

Phase 1 feasibility trial evaluating inhaled corticosteroids to prevent recurrence of acute chest syndrome in children aged 1-4 with sickle cell disease; study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chest Syndrome
• Sickle Cell Disease

Drugs mentioned

• Inhaled corticosteroids (corticosteroid, inhaled)

Snippet

Sponsor: Vanderbilt University | Conditions: Sickle Cell Disease, Asthma | Phase 1 | Status: COMPLETED